Subscribe To
Zymeworks announces participation in upcoming investor conferences
VANCOUVER, British Columbia, June 01, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel...
June 1, 2023, 12:30 pm
Dyadic to participate at upcoming events in june
JUPITER, Fla., June 01, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnolo...
June 1, 2023, 12:30 pm
3m (mmm) to invest $146m in biotech manufacturing capabilities
3M's (MMM) investment in biotech manufacturing is aimed at facility and equipment improvements and is e...
June 1, 2023, 11:05 am
Cassava sciences to present at the jefferies global healthcare conference
AUSTIN, Texas, June 01, 2023 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer's ...
June 1, 2023, 9:15 am
Zymeworks announces participation in upcoming investor conferences
VANCOUVER, British Columbia, June 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel,...
June 1, 2023, 8:30 am
2 large cap biotech stocks to watch right now
Large-cap biotech stocks to check out in the stock market today....
May 31, 2023, 4:29 pm
Generation bio to present at the 2023 jefferies healthcare conference
CAMBRIDGE, Mass., May 31, 2023 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people ...
May 31, 2023, 11:30 am
Willow biosciences signs msa with innovative biotech company to develop ingredients for age-related disease
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) told investors it has executed a Master Services Agreement (MSA) with an innovative ...
May 31, 2023, 9:02 am
Bioharvest sciences sees 1q revenue soar to us$2.2m; targets cash flow “break-even” by 4q
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) has announced that first-quarter 2023 revenue for its flagship VINIA product climbed 209% year over yea...
May 31, 2023, 8:40 am
Should you invest in the vaneck biotech etf (bbh)?
Launched on 12/20/2011, the VanEck biotech ETF (BBH) is a passively managed exchange traded fund design...
May 31, 2023, 7:30 am
Generation bio to present at the 2023 jefferies healthcare conference
CAMBRIDGE, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people l...
May 31, 2023, 7:30 am
Design therapeutics to present at the 2023 jefferies healthcare conference
CARLSBAD, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatme...
May 31, 2023, 6:30 am
Fbt: no great prospects despite huge price gain over past one year
Most stocks in FBT's biotechnology portfolio beat returns of S&P 500 during the past one year. FBT also registered a price growth of 15.5 percent. How...
May 31, 2023, 5:18 am
Novo nordisk (nvo) should remain supported & resume rally
Novo Nordisk A/S (NVO), a healthcare company engages in the research, development, manufacture and marketing of the pharmaceutical products worldwide....
May 30, 2023, 9:19 pm
Anaptysbio announces participation in upcoming investor conferences
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative ...
May 30, 2023, 8:15 pm
Io biotech to present at the jefferies healthcare conference
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- IO biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutica...
May 30, 2023, 4:35 pm
Bevy of biotech bargains in bbh
Historically, biotechnology stocks trade at premiums relative to the healthcare and the broader market. That's simply the price of admission investors...
May 30, 2023, 11:35 am
Burning rock biotech limited (bnr) q1 2023 earnings call transcript
Burning Rock biotech Limited (NASDAQ:BNR ) Q1 2023 Earnings Conference Call May 30, 2023 8:00 AM ET Com...
May 30, 2023, 10:25 am
Labu: 2 requirements for making money in this leveraged biotech fund
LABU is a 3X leveraged fund that has disappointed the biotech bulls. The sector looks beaten and perhap...
May 30, 2023, 10:00 am
Eyepoint pharmaceuticals: a puncher's chance for long acting eye disease drug success
EyePoint is a $200m market cap biotech focused on eye disease. The company's long-acting Durasert techn...
May 30, 2023, 8:00 am